|

SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK

RECRUITINGSponsored by Universitätsklinikum Hamburg-Eppendorf
Actively Recruiting
SponsorUniversitätsklinikum Hamburg-Eppendorf
Started2017-09-01
Est. completion2030-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03313687

Summary

International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients with cardiogenic shock treated at a tertiary care hospital.

Exclusion Criteria:

* Age ≤17 years.

Conditions2

Cardiogenic ShockHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.